Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art

By Britain Eakin (August 17, 2022, 5:58 PM EDT) -- A New Jersey federal judge on Wednesday dismissed an infringement suit against Bausch Health unit Salix Pharmaceuticals Ltd. over its drug Xifaxan after finding the drug product actually constitutes prior art to the four patents it was accused of infringing....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!